Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001005286-25-000126
Filing Date
2025-09-18
Accepted
2025-09-18 16:11:22
Documents
23
Period of Report
2025-09-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A lfcr-20250918.htm   iXBRL DEF 14A 881010
6 lfcr-20250918_g1.jpg GRAPHIC 19503
7 lfcr-20250918_g2.jpg GRAPHIC 401264
8 lfcr-20250918_g3.jpg GRAPHIC 371329
9 lfcr-20250918_g4.jpg GRAPHIC 367904
10 lfcr-20250918_g5.jpg GRAPHIC 544841
11 lfcr-20250918_g6.jpg GRAPHIC 251703
12 lfcr-20250918_g7.jpg GRAPHIC 446164
13 lfcr-20250918_g8.jpg GRAPHIC 251085
  Complete submission text file 0001005286-25-000126.txt   7762441

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfcr-20250918.xsd EX-101.SCH 2637
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfcr-20250918_def.xml EX-101.DEF 3043
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfcr-20250918_lab.xml EX-101.LAB 3479
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfcr-20250918_pre.xml EX-101.PRE 2095
25 EXTRACTED XBRL INSTANCE DOCUMENT lfcr-20250918_htm.xml XML 252506
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: DEF 14A | Act: 34 | File No.: 000-27446 | Film No.: 251323557
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)